Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Evenamide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Newron To Present Evenamide Schizophrenia Data At (ECNP) Congress
    Newron To Present Evenamide Schizophrenia Data At (ECNP) Congress

    02 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251002836097/en/Newron-to-Present-New-Analyses-From-and-Updates-on-its-Clinical-Program-Evaluating-Evenamide-as-an-Add-on-Treatment-for-Schizophrenia-at-the-38th-European-College-of-Neuropsychopharmacology-ECNP-Congress-2025

    BUSINESSWIRE
    02 Oct 2025
    Share Share
    Newron to Present Evenamide Data for Schizophrenia at 2025 WCBP
    Newron to Present Evenamide Data for Schizophrenia at 2025 WCBP

    05 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-05/newron-to-present-data-and-updates-on-its-clinical-program-evaluating-evenamide-as-an-add-on-treatme

    PHARMAWEB
    05 Sep 2025
    Share Share
    Newron Preclinical Data: Evenamide May Ease Schizophrenia
    Newron Preclinical Data: Evenamide May Ease Schizophrenia

    11 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250811493586/en/Newron-Notes-the-Publication-of-New-Preclinical-Research-Suggesting-Evenamide-Ameliorates-Schizophrenia-Related-Dysfunction

    BUSINESSWIRE
    11 Aug 2025
    Share Share
    Newron Preclinical Data: Evenamide Aids Schizophrenia
    Newron Preclinical Data: Evenamide Aids Schizophrenia

    11 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-11/newron-notes-the-publication-of-new-preclinical-research-suggesting-evenamide-ameliorates-schizophre

    PHARMAWEB
    11 Aug 2025
    Share Share
    Newron's Evenamide Approved for Phase III ENIGMA-TRS Program
    Newron's Evenamide Approved for Phase III ENIGMA-TRS Program

    12 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250512167812/en/Newron-Announces-Approval-for-Pivotal-Phase-III-ENIGMA-TRS-Program-With-Evenamide-as-Add-on-Therapy-in-Patients-With-Treatment-resistant-Schizophrenia-TRS

    BUSINESSWIRE
    12 May 2025
    Share Share
    Newron & Myung In Pharm Announce Agreement for evenamide in Korea
    Newron & Myung In Pharm Announce Agreement for evenamide in Korea

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250109233767/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share